What is Immuneering Corp (IMRX) stock price today?

Immuneering Corp (IMRX) currently trades at $5.34 per share. The stock has a market capitalization of $345.48M and a P/E ratio of —x.

Is IMRX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Immuneering Corp has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Immuneering Corp's revenue and earnings?

Immuneering Corp has trailing twelve-month (TTM) revenue of $455.00 with profit margins of 0.00%. Earnings per share (EPS) is $-1.27.

IMRX

Immuneering Corp

NASDAQ: IMRX · HEALTHCARE · BIOTECHNOLOGY

$5.34

-0.84% today

Updated 2026-05-05

Market cap

$345.48M

P/E ratio

—

P/S ratio

563.62x

EPS (TTM)

$-1.27

Dividend yield

—

52W range

$1 – $10

Volume

0.9M

Market cap

$345.48M

P/E ratio

—

P/S ratio

563.62x

EPS (TTM)

$-1.27

Dividend yield

—

52W range

$1 – $10

Volume

0.9M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →197 stocks currently score above 75

Price targets

Analyst target

$17.00

+218.35%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell

Price chart

Stock snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-9.96M

- Revenue declining -99.80% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$316952.00	$455.00	$0.00	$0.00	$455.00
Net income	$-50.51M	$-53.47M	$-61.04M	$-56.02M	$-11.58M
EPS	—	—	—	—	$-1.27
Free cash flow	$-44.84M	$-49.31M	$-55.08M	$-45.49M	$-9.96M
Profit margin	-15,937.29%	-11,752,004.84%	—	—	—

Recent insider activity

Date	Insider	Type	Shares	Price
2026-03-13	NEUFELD, LEAH R	Buy	3,628	$4.29
2026-02-03	ZESKIND, BENJAMIN J.	Buy	688,000	—
2026-02-03	NEUFELD, LEAH R	Buy	140,000	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
IMRX	$345.48M	27	3.7	3.0	5.0	5.0	—	Avoid
LLY	$862.01B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$546.90B	59	4.7	9.0	3.3	6.0	-40.34%	Buy
ABBV	$365.43B	63	4.0	8.0	4.0	5.0	-22.55%	Buy
UNH	$336.72B	54	5.3	5.5	7.3	4.8	+43.12%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+3.99%	Buy

Smart narrative

Immuneering Corp trades at $5.34. Our Smart Value Score of 27/100 indicates the stock is weak. TTM revenue stands at $455.00.

Frequently asked questions

What is Immuneering Corp's stock price?

Immuneering Corp (IMRX) trades at $5.34.

Is Immuneering Corp overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of Immuneering Corp (IMRX)?

The analyst target price is $17.00, representing +218.4% upside from the current price of $5.34.

What is Immuneering Corp's revenue?

TTM revenue is $455.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio563.62x

ROE-43.10%

Beta0.36

50D MA$5.32

200D MA$5.67

Shares out0.06B

Float0.05B

Short ratio—

Avg volume0.9M

Performance

1 week+9.22%

1 month+21.77%

3 months+15.71%

YTD-8.21%

1 year—

3 years—

5 years—

Compare

IMRX vs LLY →IMRX vs JNJ →IMRX vs ABBV →Stock screener →